1. Home
  2. PCVX vs FIZZ Comparison

PCVX vs FIZZ Comparison

Compare PCVX & FIZZ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • PCVX
  • FIZZ
  • Stock Information
  • Founded
  • PCVX 2013
  • FIZZ 1985
  • Country
  • PCVX United States
  • FIZZ United States
  • Employees
  • PCVX N/A
  • FIZZ N/A
  • Industry
  • PCVX Biotechnology: Pharmaceutical Preparations
  • FIZZ Beverages (Production/Distribution)
  • Sector
  • PCVX Health Care
  • FIZZ Consumer Staples
  • Exchange
  • PCVX Nasdaq
  • FIZZ Nasdaq
  • Market Cap
  • PCVX 4.0B
  • FIZZ 3.9B
  • IPO Year
  • PCVX 2020
  • FIZZ 1991
  • Fundamental
  • Price
  • PCVX $42.66
  • FIZZ $37.69
  • Analyst Decision
  • PCVX Strong Buy
  • FIZZ Strong Sell
  • Analyst Count
  • PCVX 8
  • FIZZ 1
  • Target Price
  • PCVX $114.17
  • FIZZ $39.00
  • AVG Volume (30 Days)
  • PCVX 2.0M
  • FIZZ 291.5K
  • Earning Date
  • PCVX 11-04-2025
  • FIZZ 09-11-2025
  • Dividend Yield
  • PCVX N/A
  • FIZZ N/A
  • EPS Growth
  • PCVX N/A
  • FIZZ 0.66
  • EPS
  • PCVX N/A
  • FIZZ 1.98
  • Revenue
  • PCVX N/A
  • FIZZ $1,202,396,000.00
  • Revenue This Year
  • PCVX N/A
  • FIZZ $4.63
  • Revenue Next Year
  • PCVX N/A
  • FIZZ $2.94
  • P/E Ratio
  • PCVX N/A
  • FIZZ $19.03
  • Revenue Growth
  • PCVX N/A
  • FIZZ 0.46
  • 52 Week Low
  • PCVX $27.66
  • FIZZ $36.14
  • 52 Week High
  • PCVX $118.62
  • FIZZ $50.51
  • Technical
  • Relative Strength Index (RSI)
  • PCVX 79.03
  • FIZZ 36.59
  • Support Level
  • PCVX $31.89
  • FIZZ $36.14
  • Resistance Level
  • PCVX $33.93
  • FIZZ $37.19
  • Average True Range (ATR)
  • PCVX 1.80
  • FIZZ 0.78
  • MACD
  • PCVX 1.05
  • FIZZ 0.23
  • Stochastic Oscillator
  • PCVX 96.26
  • FIZZ 56.78

About PCVX Vaxcyte Inc.

Vaxcyte Inc is a clinical-stage vaccine innovation company engineering high-fidelity vaccines to protect humankind from the consequences of bacterial diseases. It is developing broad-spectrum conjugate and novel protein vaccines to prevent or treat bacterial infectious diseases. Its product comprises of Pneumococcal conjugate vaccine. The firm's product candidate consists of VAX-31, VAX-24, VAX-A1, VAX-PG, VAX-GI, and Others.

About FIZZ National Beverage Corp.

National Beverage Corp is a non-alcoholic beverage company in the U.S. Its portfolio skews toward functional drinks (that is those purporting to offer health benefits) and is anchored by the popular LaCroix sparkling water trademark. Other offerings include Rip It energy drinks, Everfresh juices, and soda brands like Shasta and Faygo. The firm controls the majority of its production and distribution apparatus, with very little outsourcing. In terms of go-to-market, it uses warehouse distribution for retailers, direct-store delivery for convenience stores and other small outlets, and food-service distributors for the food-service channel (schools, hospitals, restaurants).

Share on Social Networks: